Filing Details
- Accession Number:
- 0001239819-18-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-16 17:20:29
- Reporting Period:
- 2018-04-12
- Accepted Time:
- 2018-04-16 17:20:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1239819 | Luna Innovations Inc | LUNA | Services-Commercial Physical & Biological Research (8731) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363589 | Clinic Carilion | C/O Luna Innovations Incorporated 301 1St Street Sw, Suite 200 Roanoke VA 24011 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-12 | 59,980 | $3.43 | 2,060,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-04-13 | 18,065 | $3.24 | 2,042,273 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-04-13 | 43,212 | $2.32 | 2,085,485 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Option (Right to Buy) | Acquisiton | 2018-04-13 | 43,212 | $0.00 | 43,212 | $2.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-14 | No | 4 | M | Direct |
Footnotes
- Price reflected is a weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.40 to $3.47 per share. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Price reflected is a weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.20 to $3.40 per share. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
